Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...
It is important to be proactive and take care to prevent and/or reduce the likelihood and impact of adverse effects associated with poly (ADP-ribose) polymerase (PARP) inhibitors. This could allow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results